Research has focused on its role in fat metabolism, adipogenesis inhibition, and metabolic regulation
A shortage of vitamin B12 in the body can lead to severe health problems
Selective NNMT inhibitor substrate site-targeting mechanism with IC50 of 1.2 M in reference assay conditions Selectivity over related methyltransferases does not significantly affect other enzymes in the NAD salvage pathway at research concentrations Reduces intracellular 1-methylnicotinamide (1-MNA) formation in cell-based assay models Studied in adipocyte, liver, and skeletal muscle cell-based research models examining NNMT-dependent methylation pathway dynamics Referenced at Sigma-Aldrich (SML2832) and in peer-reviewed literature on NNMT enzyme biology Membrane-permeable quaternary quinolinium scaffold studied for intracellular NNMT target engagement in cell-based models Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background 5-Amino-1MQ was first characterized as a selective NNMT inhibitor in published research literature in 2018

The potential benefits of AOD 9604, particularly in the context of weight management and obesity, are promising based on its mechanism of action: As with any peptide or medication, AOD 9604 comes with potential risks that need careful consideration: Research studies have provided some insights into the effectiveness and safety of AOD 9604: AOD 9604 offers intriguing possibilities in the realms of weight management, sports performance enhancement, and perhaps even musculoskeletal healing
Allow the vial and BAC water to reach room temperature if refrigerated
Tesamorelin (a GHRH analog) targets visceral fat through the GH/IGF-1 axis